NCLEX Review Guide: Pediatric Cardiovascular - Hyperlipidemia

Understanding Pediatric Hyperlipidemia

• Hyperlipidemia in children is defined as elevated cholesterol levels >200 mg/dL or LDL >130 mg/dL, which can lead to early atherosclerosis and cardiovascular disease in adulthood.
• Primary hyperlipidemia results from genetic factors (familial hypercholesterolemia), while secondary causes include obesity, diabetes, hypothyroidism, and certain medications.
• Family history of early coronary artery disease (men <55 years, women <65 years) is the strongest risk factor requiring immediate screening and intervention.

Screening Protocols

• Universal screening recommended at ages 9-11 years and 17-21 years with fasting lipid panel to identify children at risk.
• Targeted screening begins at age 2 years for high-risk children with family history of dyslipidemia or premature cardiovascular disease.
• Physical assessment includes measuring BMI, blood pressure, and examining for xanthomas (yellowish deposits) around eyes, tendons, or skin folds.

Treatment Approaches

1. First-line treatment: Dietary modifications including <30% calories from fat, <7% from saturated fat, and <200mg cholesterol daily
2. Physical activity: Encourage 60 minutes of moderate-to-vigorous activity daily with family participation
3. Pharmacological therapy: Consider statins for children ≥10 years with LDL >190 mg/dL or >160 mg/dL with risk factors
4. Family-centered approach: Involve entire family in lifestyle changes to ensure sustainable modifications

NCLEX Success Strategies

• Priority questions: Always choose lifestyle modifications before medications for pediatric hyperlipidemia management.
• Safety first: Monitor for muscle pain, weakness, or elevated liver enzymes when children are on statin therapy.
• Family education: Teach parents that dietary changes must involve the entire family to be effective and sustainable.